Multi-Peptide Blends · Research deep dive
Tesa/Ipa 2X Blend (12mg / 3mg): the cited literature
Every study referenced in the Tesa/Ipa 2X Blend (12mg / 3mg) monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Tesa/Ipa 2X Blend (12mg / 3mg) is studied at 300 mcg – 600 mcg per administration, typically once nightly (combined peptide mass). The reference walkthrough below maps each citation to what it actually showed.
References covered
Tesamorelin pharmacology review
Drugs, 2011
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Tesa/Ipa 2X Blend (12mg / 3mg).